Sarah Grant

Company: AstraZeneca
Job title: Vice President & Head of Early Clinical Development Respiratory & Immunology
Seminars:
Targeting CCR9: Advancing Precision Therapies for Inflammatory Bowel Disease 12:00 pm
Leveraging CCR9 inhibition to improve therapeutic targeting and address IBD heterogeneitys Exploring clinical outcomes and patient stratification strategies for CCR9-targeted therapies Innovating treatment pathways to optimize safety and efficacy in precision medicine for IBDRead more
day: Day Two